Leelyn Smith, LLC Biogen Inc. Transaction History

Leelyn Smith, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$252.44 - $306.72 $19,690 - $23,924	-78 Reduced 69.03%	35 $9,000
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $241,026 - $332,353	-1,238 Reduced 91.64%	113 $30,000
Q2 2022 Aug 09, 2022	SELL	$187.54 - $223.02 $1.62 Million - $1.92 Million	-8,620 Reduced 86.45%	1,351 $276,000
Q1 2022 May 11, 2022	BUY	$193.77 - $244.14 $376,495 - $474,364	1,943 Added 24.2%	9,971 $2.1 Million
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $17,465 - $22,446	78 Added 0.98%	8,028 $1.93 Million
Q3 2021 Nov 12, 2021	BUY	$282.99 - $369.05 $233,466 - $304,466	825 Added 11.58%	7,950 $2.25 Million
Q2 2021 Aug 31, 2021	SELL	$259.0 - $414.71 $112,924 - $180,813	-436 Reduced 5.77%	7,125 $2.47 Million
Q1 2021 May 05, 2021	BUY	$242.95 - $284.63 $83,817 - $98,197	345 Added 4.78%	7,561 $2.12 Million
Q4 2020 Jan 15, 2021	BUY	$236.26 - $355.63 $160,893 - $242,184	681 Added 10.42%	7,216 $1.77 Million
Q3 2020 Nov 05, 2020	BUY	$264.77 - $305.71 $194,605 - $224,696	735 Added 12.67%	6,535 $1.85 Million
Q2 2020 Aug 06, 2020	BUY	$258.66 - $342.55 $162,179 - $214,778	627 Added 12.12%	5,800 $1.12 Million
Q1 2020 May 06, 2020	BUY	$268.85 - $341.04 $314,016 - $398,334	1,168 Added 29.16%	5,173 $1.64 Million
Q4 2019 Feb 06, 2020	BUY	$220.06 - $304.07 $881,340 - $1.22 Million	4,005 New	4,005 $1.19 Million

1,006

129M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Leelyn Smith, LLC, based on Form 13F filings with the SEC.

Stay updated on Leelyn Smith, LLC with notifications on news.